Evaluation of treatment with progesterone in controlled ovarian stimulation for patients undergoing IVF/ICSI cycles to prevent ovulation: a randomized clinical trial
Not Applicable
- Conditions
- Infertility
- Registration Number
- JPRN-UMIN000035469
- Lead Sponsor
- Hanabusa Womens' clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients with ovulatory disturbance caused by reduced hypothalamic or pituitary activity 2 Patients who can not use GnRH-agonist nasal spray for triggering final oocyte maturation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the incidence of ovulation before oocyte retrieval
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of progesterone prevent ovulation in controlled ovarian stimulation for IVF/ICSI?
How does progesterone treatment compare to standard-of-care protocols in IVF/ICSI cycles for infertility management?
Which biomarkers correlate with successful patient selection for progesterone-based ovarian stimulation in infertility?
What are the potential adverse events associated with progesterone use in controlled ovarian stimulation for IVF/ICSI?
Are there combination therapies involving progesterone and other gonadotropins to enhance IVF/ICSI outcomes in infertility?